APA aipamena

He, M., Li, Q., Zou, R., Shen, J., Fang, W., Tan, G., . . . Shi, M. (2019). Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion: A Randomized Clinical Trial. JAMA Oncol.

Chicago Style aipamena

He, MinKe, et al. "Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion: A Randomized Clinical Trial." JAMA Oncol 2019.

MLA aipamena

He, MinKe, et al. "Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion: A Randomized Clinical Trial." JAMA Oncol 2019.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.